Jamieson Bondarenko, CFA, CMT is a private investor and provides strategic capital markets & corporate development advice to early-stage life science and disruptive technology companies.  Jamieson is currently the Chairman of BriaCell Therapeutics and Capital Markets Advisor with MustGrow Biologics.

His previous roles include Equity Capital Markets and Investment Banking positions at Eight Capital, Dundee Capital Markets, Wellington West Capital Markets, and HSBC Securities.  Jamieson is a CFA Charterholder and a Chartered Market Technician.